EUVIMEDEUVIMED entdecken
Crossref

Determination of Posaconazole in Serum From Patients Undergoing Treatment for Hematological Malignancies by High‐Performance Liquid Chromatography With Electrochemical Detection

Akira Kotani, Keishiro Kuniyoshi, Masaaki Ito, Yusuke Yagi, Kohei Jobu, Yukihiro Hamada, Koichi Machida, Hideki Hakamata

Electroanalysis · 2026-11 · 38 (11)

DOI: 10.1002/elan.70252 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Electroanalysis, online erschienen am 09.11.2026. Verfasst von Akira Kotani und 7 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A high‐performance liquid chromatography system coupled with electrochemical detection (HPLC‐ECD) was developed for the determination of posaconazole (PSCZ). Chromatographic separation was achieved on an octadecylsilyl (ODS) column with an internal diameter of 1.0 mm using a mobile phase consisting of water–acetonitrile–formic acid (60:40:0.5, v/v/v) delivered at 50 μL/min. The applied potential for PSCZ detection was set at +0.65 V versus Ag/AgCl based on hydrodynamic voltammetry. Under these conditions, PSCZ was eluted at 6.8 min. Peak height showed a linear response over the concentration range of 2.0 μg/L to 1.0 mg/L ( r = 0.999). The limit of detection was 0.67 μg/L (signal‐to‐noise ratio, S/N = 3). The HPLC‐ECD method was applied to the determination of PSCZ concentrations in serum of three patients undergoing treatment for hematological malignancies and receiving PSCZ delayed‐release tablets at a maintenance dose of 300 mg/day. In the quantitative analysis, the repeatability was within a relative standard deviation (RSD) of 2.4% ( n = 5), and their recoveries exceeded 95.7% with an RSD below 2.5% ( n = 5). In conclusion, the proposed HPLC‐ECD method provides sensitive, accurate, and precise quantification of PSCZ in human serum and is suitable for clinical application.

Zitieren

APA

Kotani, A., Kuniyoshi, K., Ito, M., Yagi, Y., Jobu, K., Hamada, Y., Machida, K., & Hakamata, H. (2026). Determination of Posaconazole in Serum From Patients Undergoing Treatment for Hematological Malignancies by High‐Performance Liquid Chromatography With Electrochemical Detection. Electroanalysis, 38(11). https://doi.org/10.1002/elan.70252

Vancouver

Kotani A, Kuniyoshi K, Ito M, Yagi Y, Jobu K, Hamada Y, et al. Determination of Posaconazole in Serum From Patients Undergoing Treatment for Hematological Malignancies by High‐Performance Liquid Chromatography With Electrochemical Detection. Electroanalysis. 2026;38(11). doi:10.1002/elan.70252

BibTeX
@article{Kotani2026,
  author = {Kotani, Akira and Kuniyoshi, Keishiro and Ito, Masaaki and Yagi, Yusuke and Jobu, Kohei and Hamada, Yukihiro and Machida, Koichi and Hakamata, Hideki},
  title = {Determination of Posaconazole in Serum From Patients Undergoing Treatment for Hematological Malignancies by High‐Performance Liquid Chromatography With Electrochemical Detection},
  journal = {Electroanalysis},
  year = {2026},
  volume = {38},
  number = {11},
  doi = {10.1002/elan.70252}
}
Kostenlos starten →